The role of morphine in animal models of human cancer: Does morphine promote or inhibit the tumor growth?

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Bimonte, Sabrina ^a   Barbieri, Antonio ^a   Palma, Giuseppe ^a,b   Arra, Claudio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; MORPHINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER PAIN; CARCINOGENESIS; CELL LINE; CELL STRAIN MCF 7; CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; ENDOTHELIUM CELL; MDA MB231 CANCER CELL; METASTASIS; MOUSE; NONHUMAN; REVIEW; TUMOR CELL; TUMOR GROWTH; ANIMAL; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECTS; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION; DRUG EFFECT;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; MORPHINE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84884277701     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/258141     Document Type: Review

References (55)

1. Lickiss J. N., Approaching cancer pain relief. European Journal of Pain 2001 5 5 14 2-s2.0-0035693630 10.1053/eujp.2001.0273
2. Schmitz R., Friedrich Wilhelm Sertürner and the discovery of morphine. Pharmacy in history 1985 27 2 61 74 2-s2.0-0021778837
3. Pasternak G. W., Pharmacological mechanisms of opioid analgesics. Clinical Neuropharmacology 1993 16 1 1 18 2-s2.0-0027471855
4. Kieffer B. L., Gavériaux-Ruff C., Exploring the opioid system by gene knockout. Progress in Neurobiology 2002 66 5 285 306 2-s2.0-0036095186 10.1016/S0301-0082(02)00008-4
5. Mantyh P. W., Cancer pain and its impact on diagnosis, survival and quality of life. Nature Reviews Neuroscience 2006 7 10 797 809 2-s2.0-33748934201 10.1038/nrn1914
6. Sueoka N., Sueoka E., Okabe S., Fujiki H., Anti-cancer effects of morphine through inhibition of tumour necrosis factor- α release and mRNA expression. Carcinogenesis 1996 17 11 2337 2341 2-s2.0-0029830205
7. Maneckjee R., Minna J. D., Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth and Differentiation 1994 5 10 1033 1040 2-s2.0-0027985282
8. Pasi A., Qu B., Steiner R., Senn H.-J., Bar W., Messiha F. S., Angiogenesis: modulation with opioids. General Pharmacology 1991 22 6 1077 1079 2-s2.0-0025994905 10.1016/0306-3623(91)90580-Y
9. Hatzoglou A., Bakogeorgou E., Papakonstanti E., Stournaras C., Emmanouel D. S., Castanas E., Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. Journal of Cellular Biochemistry 1996 63 4 410 421
10. Hatzoglou A., Ouafik L., Bakogeorgou E., Thermos K., Castanas E., Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Research 1995 55 23 5632 5636 2-s2.0-0028839677
11. Maneckjee R., Biswas R., Vonderhaar B. K., Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Research 1990 50 8 2234 2238 2-s2.0-0025252232
12. Kampa M., Bakogeorgou E., Hatzoglou A., Damianaki A., Martin P.-M., Castanas E., Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. European Journal of Pharmacology 1997 335 2-3 255 265 2-s2.0-0030823262 10.1016/S0014-2999(97)01213-2
13. Tegeder I., Grösch S., Schmidtko A., Häussler A., Schmidt H., Niederberger E., Scholich K., Geisslinger G., G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Research 2003 63 8 1846 1852 2-s2.0-0037446984
14. Yeager M. P., Colacchio T. A., Effect of morphine on growth of metastatic colon cancer in vivo. Archives of Surgery 1991 126 4 454 456 2-s2.0-0025730229
15. Sasamura T., Nakamura S., Iida Y., Fujii H., Murata J., Saiki I., Nojima H., Kuraishi Y., Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. European Journal of Pharmacology 2002 441 3 185 191 2-s2.0-0037177363 10.1016/S0014-2999(02)01450-4
16. Harimaya Y., Koizumi K., Andoh T., Nojima H., Kuraishi Y., Saiki I., Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Letters 2002 187 1-2 121 127 2-s2.0-0037058648 10.1016/S0304-3835(02)00360-9
17. Simon R. H., Arbo T. E., Morphine increases metastatic tumor growth. Brain Research Bulletin 1986 16 3 363 367 2-s2.0-0022887158
18. Lewis J. W., Shavit Y., Terman G. W., Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 1983 4 5 635 638 2-s2.0-0021084707 10.1016/0196-9781(83)90010-4
19. Sergeeva M. G., Grishina Z. V., Varfolomeyev S. D., Morphine effect on proliferation of normal and tumor cells of immune origin. Immunology Letters 1993 36 2 215 218 2-s2.0-0027167859 10.1016/0165-2478(93)90055-7
20. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P.-Y., Yee D., Hebbel R. P., Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Research 2002 62 15 4491 4498 2-s2.0-0036682055
21. Farooqui M., Li Y., Rogers T., Poonawala T., Griffin R. J., Song C. W., Gupta K., COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. British Journal of Cancer 2007 97 11 1523 1531 2-s2.0-36448965294 10.1038/sj.bjc.6604057
22. Ishikawa M., Tanno K., Kamo A., Takayanagi Y., Sasaki K.-I., Enhancement of tumor growth by morphine and its possible mechanism in mice. Biological and Pharmaceutical Bulletin 1993 16 8 762 766 2-s2.0-0027490626
23. Zong J., Pollack G. M., Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharmaceutical Research 2000 17 6 749 753 2-s2.0-0033844780 10.1023/A:1007546719287
24. Iglesias M., Segura M. F., Comella J. X., Olmos G., -opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 2003 44 4 482 492 2-s2.0-0037333912 10.1016/S0028-3908(03) 00024-8
25. Gach K., Szemraj J., Fichna J., Piestrzeniewicz M., Delbro D. S., Janecka A., The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line. Chemical Biology and Drug Design 2009 74 4 390 396 2-s2.0-70349098155 10.1111/j.1747-0285.2009.00875.x
26. Singleton P. A., Moss J., Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncology 2010 6 8 1237 1242 2-s2.0-77956311003 10.2217/fon.10.99
27. Chen C., Farooqui M., Gupta K., Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Current Neurovascular Research 2006 3 3 171 180 2-s2.0-33746893866 10.2174/ 156720206778018767
28. Green D. R., Reed J. C., Mitochondria and apoptosis. Science 1998 281 5381 1309 1312 2-s2.0-0032575752
29. Ashkenazi A., Dixit V. M., Apoptosis control by death and decoy receptors. Current Opinion in Cell Biology 1999 11 2 255 260 2-s2.0-0032910169 10.1016/S0955-0674(99)80034-9
30. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 10.1016/S0092-8674(00)81683-9
31. Hengartner M. O., The biochemistry of apoptosis. Nature 2000 407 6805 770 776 2-s2.0-0034641918 10.1038/35037710
32. Hsiao P.-N., Chang M.-C., Cheng W.-F., Chen C.-A., Lin H.-W., Hsieh C.-Y., Sun W.-Z., Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology 2009 256 1-2 83 91 2-s2.0-58149233834 10.1016/j.tox.2008.11.015
33. Kapasi A. A., Coscia S. A., Pandya M. P., Singhal P. C., Morphine modulates HIV-1 gp160-induced murine macrophage and human monocyte apoptosis by disparate ways. Journal of Neuroimmunology 2004 148 1-2 86 96 2-s2.0-1242295126 10.1016/j.jneuroim.2003.11.015
34. Lin X., Li Q., Wang Y.-J., Ju Y.-W., Chi Z.-Q., Wang M.-W., Liu J.-G., Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor B transcriptional activation in neuroblastoma SH-SY5Y cells. Biochemical Journal 2007 406 2 215 221 2-s2.0-34548149470 10.1042/BJ20070186
35. Arerangaiah R., Chalasani N., Udager A. M., Weber M. L., Manivel J. C., Griffin R. J., Song C. W., Gupta K., Opioids induce renal abnormalities in tumor-bearing mice. Nephron-Experimental Nephrology 2007 105 3 e80 e89 2-s2.0-33847701709 10.1159/000098564
36. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P., Nitric oxide activates cyclooxygenase enzymes. Proceedings of the National Academy of Sciences of the United States of America 1993 90 15 7240 7244 2-s2.0-0027249753
37. Nédélec E., Abid A., Cipolletta C., Presle N., Terlain B., Netter P., Jouzeau J.-Y., Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochemical Pharmacology 2001 61 8 965 978 2-s2.0-0035871921 10.1016/S0006-2952(01)00559-7
38. Farooqui M., Geng Z. H., Stephenson E. J., Zaveri N., Yee D., Gupta K., Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells. Molecular Cancer Therapeutics 2006 5 3 611 620 2-s2.0-33645471586 10.1158/1535-7163.MCT-05-0016
39. Salvemini D., Seibert K., Masferrer J. L., Misko T. P., Currie M. G., Needleman P., Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. Journal of Clinical Investigation 1994 93 5 1940 1947 2-s2.0-0028268947
40. Griffin R. J., Williams B. W., Wild R., Cherrington J. M., Park H., Song C. W., Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Research 2002 62 6 1702 1706 2-s2.0-0037085933
41. Leahy K. M., Ornberg R. L., Wang Y., Zweifel B. S., Koki A. T., Masferrer J. L., Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Research 2002 62 3 625 631 2-s2.0-0036468287
42. Chang S. H., Liu C. H., Conway R., Han D. K., Nithipatikom K., Trifan O. C., Lane T. F., Hla T., Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America 2004 101 2 591 596
43. Lam C.-F., Liu Y.-C., Tseng F.-L., Sung Y.-H., Huang C.-C., Jiang M.-J., Tsai Y.-C., High-dose morphine impairs vascular endothelial function by increased production of superoxide anions. Anesthesiology 2007 106 3 532 537 2-s2.0-34247512935 10.1097/00000542-200703000-00018
44. Blebea J., Mazo J. E., Kihara T. K., Vu J.-H., McLaughlin P. J., Atnip R. G., Zagon I. S., Opioid growth factor modulates angiogenesis. Journal of Vascular Surgery 2000 32 2 364 373 2-s2.0-0033836186 10.1067/mva.2000.107763b
45. Lam C.-F., Chang P.-J., Huang Y.-S., Sung Y.-H., Huang C.-C., Lin M.-W., Liu Y.-C., Tsai Y.-C., Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice. Anesthesia and Analgesia 2008 107 2 686 692 2-s2.0-49949094428 10.1213/ane.0b013e31817e6719
46. Martin J. L., Charboneau R., Barke R. A., Roy S., Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cellular Immunology 2010 265 2 139 145 2-s2.0-77957020506 10.1016/j.cellimm. 2010.08.002
47. Roy S., Balasubramanian S., Wang J., Chandrashekhar Y., Charboneau R., Barke R., Morphine inhibits VEGF expression in myocardial ischemia. Surgery 2003 134 2 336 344 2-s2.0-0042829165 10.1067/msy.2003.247
48. Koodie L., Ramakrishnan S., Roy S., Morphine suppresses tumor angiogenesis through a HIF-1 α /p38MAPK pathway. American Journal of Pathology 2010 177 2 984 997 2-s2.0-77957275033 10.2353/ajpath.2010.090621
49. Faramarzi N., Abbasi A., Tavangar S. M., Mazouchi M., Dehpour A. R., Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats. Journal of Gastroenterology and Hepatology 2009 24 7 1226 1229 2-s2.0-68749119965 10.1111/j.1440-1746.2009.05794.x
50. Shapiro R. L., Duquette J. G., Roses D. F., Nunes I., Harris M. N., Kamino H., Wilson E. L., Rifkin D. B., Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals. Cancer Research 1996 56 15 3597 3604 2-s2.0-0029682495
51. Engbring J. A., Kleinman H. K., The basement membrane matrix in malignancy. Journal of Pathology 2003 200 4 465 470 2-s2.0-0038236716 10.1002/path.1396
52. Widel M. S., Widel M., Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer. Postȩpy Higieny i Medycyny Doświadczalnej 2006 60 453 470
53. Lynch C. C., Matrisian L. M., Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002 70 9-10 561 573 2-s2.0-0036995757 10.1046/j.1432-0436.2002.700909.x
54. Gach K., Szemraj J., Wyrbska A., Janecka A., The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line. Molecular Biology Reports 2011 38 2 1231 1236 2-s2.0-79951578303 10.1007/s11033-010-0222-z
55. Nylund G., Pettersson A., Bengtsson C., Khorram-Manesh A., Nordgren S., Delbro D. S., Functional expression of -opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Digestive Diseases and Sciences 2008 53 2 461 466 2-s2.0-38649143679 10.1007/s10620-007- 9897-y